Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Cellular Signalling|August 23, 2011
A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitinationVaibhav Kapuria, Alexander Levitzki, William G Bornmann, et al.
Transplantation|November 27, 2002
Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295Matthias Karck, Rolf Meliss, Michael Hestermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in miceYael Langut, Alaa Talhami, Samarasimhareddy Mamidi, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and KitAviv Gazit, Kevin Yee, Andrea Uecker, et al.
Cardiovascular Research|September 15, 2004
Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteriesShmuel Banai, S David Gertz, Lilach Gavish, et al.
Journal of Medicinal Chemistry|June 10, 2011
Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt)Yftah Tal-Gan, Mattan Hurevich, Shoshana Klein, et al.
Plos One|May 5, 2026
EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFRAnne Pettikiriarachchi, Yelena Ugolev, Richard Birkinshaw, et al.
Cancer Immunology Research|June 1, 2016
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune MicroenvironmentMaya Zigler, Alexei Shir, Salim Joubran, et al.
Cancer Biology & Therapy|January 17, 2004
The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformationHong He, Yumiko Hirokawa, Aviv Gazit, et al.
Molecular Cancer Therapeutics|December 17, 2002
Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent aloneLyudmila Burdelya, Robyn Catlett-Falcone, Alexander Levitzki, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Cellular Signalling|August 23, 2011
A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitinationVaibhav Kapuria, Alexander Levitzki, William G Bornmann, et al.
Transplantation|November 27, 2002
Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295Matthias Karck, Rolf Meliss, Michael Hestermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in miceYael Langut, Alaa Talhami, Samarasimhareddy Mamidi, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and KitAviv Gazit, Kevin Yee, Andrea Uecker, et al.
Cardiovascular Research|September 15, 2004
Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteriesShmuel Banai, S David Gertz, Lilach Gavish, et al.
Journal of Medicinal Chemistry|June 10, 2011
Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt)Yftah Tal-Gan, Mattan Hurevich, Shoshana Klein, et al.
Plos One|May 5, 2026
EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFRAnne Pettikiriarachchi, Yelena Ugolev, Richard Birkinshaw, et al.
Cancer Immunology Research|June 1, 2016
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune MicroenvironmentMaya Zigler, Alexei Shir, Salim Joubran, et al.
Cancer Biology & Therapy|January 17, 2004
The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformationHong He, Yumiko Hirokawa, Aviv Gazit, et al.
Molecular Cancer Therapeutics|December 17, 2002
Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent aloneLyudmila Burdelya, Robyn Catlett-Falcone, Alexander Levitzki, et al.
Pageof 10